Activation of α-secretase by curcumin-aminoacid conjugates

Biochemical and Biophysical Research Communications

Volumn 424, Issue 4, 2012, Pages 691-696

  Narasingapa, Ramesh B ^a   Jargaval, Manjunatha R ^b   Pullabhatla, Srinivas ^b   Htoo, Htut Htut ^a   Rao, Jagannatha K S ^c   Hernandez, Jean François ^d   Govitrapong, Piyarat ^a   Vincent, Bruno ^a,e  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CENTRAL FOOD TECHNOLOGICAL RESEARCH INSTITUTE   (India)

^c INSTITUTO DE INVESTIGACIONES CIENTÍFICAS Y SERVICIOS DE ALTA TECNOLOGÍA   (Panama)

^d UNIVERSITÉ DE MONTPELLIER   (France)

^e JAIN UNIVERSITY   (India)

Author keywords

Secretase; APP; Alzheimer; Curcumin; Disintegrins; Muscarinic receptors

Indexed keywords

ADAM10 ENDOPEPTIDASE; ALPHA SECRETASE; CURCUMIN; ISOLEUCINE; MUSCARINIC RECEPTOR; PHENYLALANINE; PROTEIN KINASE C; VALINE;

ARTICLE; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PRIORITY JOURNAL;

ADAM PROTEINS; ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; CURCUMIN; ENZYME ACTIVATION; HEK293 CELLS; HUMANS; ISOLEUCINE; MEMBRANE PROTEINS; PHENYLALANINE; VALINE;

EID: 84864813737     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.07.010     Document Type: Article

References (32)

1. Checler F. Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 1995, 65:1431-1444.
2. Searfoss G.H., Joran W.H., Calligaro D.O., Galbreath E.J., Schirtzinger L.M., Berridge B.R., Gao H., Higgins M.A., May P.C., Ryan T.P. Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional γ-secretase inhibitor. J. Biol. Chem. 2003, 278:46107-46116.
3. Wong G.T., Manfra D., Poulet F.M., Zhang Q., Josien H., Bara T., Engstrom L., Pinzon-Ortiz M., Fine J.S., Lee H.J.J., Zhang L., Higgins G.A., Parker E.M. Chronic treatment with the γ-secretase inhibitor LY-411,575 inhibits β-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J. Biol. Chem. 2004, 279:12876-12882.
4. Willem M., Garratt A.N., Novak B., Citron M., Kaufmann S., Rittger A., DeStrooper B., Saftig P., Birchmeier C., Haass C. Control of peripheral nerve myelination by the beta-secretase BACE1. Science 2006, 314:664.
5. Hu X., Hicks C.W., He W., Wong P., Macklin W.B., Trapp B.D., Yan R. BACE1 modulates myelination in the central and peripheral nervous system. Nat. Neurosci. 2006, 9:1520-1525.
6. Vincent B., Govitrapong P. Activation of the α-secretase processing of AβPP as a therapeutic approach in Alzheimer's disease. J. Alz. Dis. 2011, 24:75-94.
7. Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C., Fahrenholz F. Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. USA 1999, 96:3922-3927.
8. Buxbaum J.D., Liu K.N., Luo Y., Slack J.L., Stocking K.L., Peschon J.J., Johnson R.S., Castner B.J., Cerretti D.P., Black R.A. Evidence that tumor necrosis factor α-converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 1998, 273:27765-27767.
9. Alkon D.L., Sun M.K., Nelson T.J. PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease. Trends Pharmacol. Sci. 2007, 28:51-60.
10. Nitsch R.M., Slack B.E., Wurtman R.J., Growdon J.H. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 1992, 258:304-307.
11. Caccamo A., Oddo S., Billings L.M., Green K.N., Martinez-Coria H., Fisher A., LaFerla F.M. M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 2006, 49:671-682.
12. Etcheberrigaray R., Tan M., Dewachter I., Kuipéri C., Van der Auwera I., Wera S., Qiao L., Bank B., Nelson T.J., Kozikowski A.P., Van Leuven F., Alkon D.L. Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice. Proc. Natl. Acad. Sci. USA 2004, 101:11141-11146.
13. Vincent B., Checler F. α-Secretase in Alzheimer's disease and beyond: mechanistic, regulation and function in the shedding of membrane proteins. Curr. Alz. Res. 2012, 9:140-156.
14. Colciaghi F., Borroni B., Zimmermann M., Bellone C., Longhi A., Padovani A., Cattabeni F., Christen Y., Di Luca M. Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts. Neurobiol. Dis. 2004, 16:454-460.
15. Levites Y., Amit T., Mandel S., Youdim M.B. Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. FASEB J. 2003, 17:952-954.
16. Shen L., Ji H.F. The pharmacology of curcumin: is it the degradation products?. Trends Mol. Med. 2012, 18:138-144.
17. Liu H., Li Z., Qiu D., Gu Q., Lei Q., Mao L. The inhibitory effects of different curcuminoids on β-amyloid protein, β-amyloid precursor protein and β-site amyloid precursor protein cleaving enzyme 1 in swAPP HEK293 cells. Neurosci. Lett. 2010, 485:83-88.
18. Zhang C., Browne A., Child D., Tanzi R.E. Curcumin decreases amyloid-β peptide levels by attenuating the maturation of amyloid-β precursor protein. J. Biol. Chem. 2010, 285:28472-28480.
19. Baum L., Lam C.W., Cheung S.K., Kwok T., Lui V., Tsoh J., Lam L., Leung V., Hui E., Ng C., Woo J., Chiu H.F., Goggins W.B., Zee B.C., Cheng K.F., Fong C.Y., Wong A., Mok H., Chow M.S., Ho P.C., Ip S.P., Ho C.S., Yu X.W., Lai C.Y., Chan M.H., Szeto S., Chan I.H., Mok V. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J. Clin. Psychopharmacol. 2008, 28:110-113.
20. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol. Pharmacol. 2007, 4:807-818.
21. Alfa Cissé M., Gandreuil C., Hernandez J.F., Martinez J., Checler F., Vincent B. Design and characterization of a novel cellular prion-derived quenched fluorimetric substrate of alpha-secretase. Biochem. Biophys. Res. Commun. 2006, 347:254-260.
22. Vincent B., Paitel E., Frobert Y., Lehmann S., Grassi J., Checler F. Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons. J. Biol. Chem. 2000, 275:35612-35616.
23. Vincent B., Paitel E., Saftig P., Frobert Y., Hartmann D., de Strooper B., Grassi J., Lopez-Perez E., Checler F. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol-esters-regulated normal cleavage of the cellular prion protein. J. Biol. Chem. 2001, 276:37743-37746.
24. Alfa Cissé M., Sunyach C., Slack B.E., Fisher A., Vincent B., Checler F. M1 and M3 muscarinic receptors control physiological processing of cellular prion by modulating ADAM17 phosphorylation and activity. J. Neurosci. 2007, 27:4083-4092.
25. Chevallier N., Jiracek J., Vincent B., Baur C.P., Spillantini M.G., Goedert M., Dive V., Checler F. Examination of the role of endopeptidase in Aβ secretion by human transfected cells. Brit. J. Pharmacol. 1997, 121:556-562.
26. Parvathy K.S., Negi P.S., Srinivas P. Curcumin-amino acid conjugates: synthesis, antioxidant and antimutagenic attributes. Food Chem. 2010, 120:523-530.
27. M.M. Essa, R.K. Vijayan, G. Castellano-Gonzalez, M.A. Memon, N. Braidy, G.J. Guillemin, Neuroprotective effect of natural products against Alzheimer's disease, Neurochem. Res., in press.
28. Dhanasekaran M., Holcomb L.A., Hitt A.R., Tharakan B., Porter J.W., Young K.A., Manyam B.V. Centella asiatica extract selectively decreases amyloid beta levels in hippocampus of Alzheimer's disease animal model. Phytother. Res. 2009, 23:14-19.
29. Solomon P.R., Adams F., Silver A., Zimmer J., DeVeaux R. Ginkgo for memory enhancement: a randomized controlled trial. JAMA 2002, 288:835-840.
30. Fujiwara H., Tabuchi M., Yamaguchi T., Iwasaki K., Furukawa K., Sekiguchi K., Ikarashi Y., Kudo Y., Higuchi M., Saido T.C., Maeda S., Takashima A., Hara M., Yaegashi N., Kase Y., Arai H. A traditional medicinal herb Paeonia suffruticosa and its active constituent 1,2,3,4,6-penta-O-galloyl-beta-d-glucopyranose have potent anti-aggregation effects on Alzheimer's amyloid beta proteins in vitro and in vivo. J. Neurochem. 2009, 109:1648-1657.
31. Ahmed T., Gilani A.H. A comparative study of curcuminoids to measure their effect on inflammatory and apoptotic gene expression in an Aβ plus ibotenic acid-infused rat model of Alzheimer's disease. Brain Res. 2011, 1400:1-18.
32. Menon V.P., Sudheer A.R. Antioxidant and anti-inflammatory properties of curcumin. Adv. Exp. Med. Biol. 2007, 595:105-125.